Sangamo Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Good morning. I'm Eric Joseph, senior biotech analyst here at JPMorgan. And our next presenting company is Sangamo Therapeutics. I'm pleased to welcome CEO, Sandy Macrae, to tell us a little bit about the company. Following the presentation, the breakout Q&A will be across the hall in the Georgian room. With that, Sandy?
Thanks, Eric. Good morning. I'm Sandy. I have the privilege to lead Sangamo. I would refer you, of course, to our forward-looking statement. And I want to give a talk today that is about balance and about responsibility. We had an R&D day just last month, and there's some excellent presentations there that will give you the full detail on the programs. So I want to give an overview of how we think about Sangamo and the balance and responsibility that we have.
And we have a responsibility to patients, of course. We have a responsibility to you all to make
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |